Fragment screening and high throughput screening are complementary approaches that combine with structural biology to explore the binding capabilities of an active site. We have used a fragment-based approach on malate synthase (GlcB) from Mycobacterium tuberculosis and discovered several novel binding chemotypes. In addition, the crystal structures of GlcB in complex with these fragments indicated conformational changes in the active site that represent the enzyme conformations during catalysis. Additional structures of the complex with malate and of the apo form of GlcB supported that hypothesis. Comparative analysis of GlcB structures in complex with 18 fragments allowed us to characterize the preferred chemotypes and their binding modes. The fragment structures showed a hydrogen bond to the backbone carbonyl of Met-631. We successfully incorporated an indole group from a fragment into an existing phenyl-diketo acid series. The resulting indole-containing inhibitor was 100-fold more potent than the parent phenyl-diketo acid with an IC50 value of 20 nm.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hytswW
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 8 April 2017 Source: Cortex Author(s): Jeremy Purcell, Rajani Sebastian, Richard Leigh, Samson Jarso,...
-
With a highly professional, friendly and compassionate staff, Coral Springs Funeral Home is the first choice for hundreds of area families e...
-
OBJECTIVE: This study was aimed to explore the underlying genes associated with lung cancer (LC) by bioinformatics analysis. DATA AND METH...
-
The impact of industrialised societies on Earth has been described in a mathematical formula that should scare us all, says Owen Gaffney ...
-
Astrophel' is a fanciful half-Greek anagram for the poet's own name, and Stella (Star) designates Lady Penelope Devereux, who at abo...
-
Abstract: Patients with neurofibromatosis type 1 (NF-1) have a well-known predisposition for certain types of malignancies, including lympho...
-
Biomarkers for Hearing Dysfunction: Facts and Outlook. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):93-111 Authors: Rüttige...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2p4oxom via IFTTT
-
Prof. Murray Leibbrandt - Professor and SALDRU Director. About Books and Book Chapters Publications and Working Papers. 021 650 2726: @: 3 ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου